Decheng Capital LLC
- SEC CIK
- 0002010850
- Latest filing
- Aug 14, 2026
PHAT holding history
Phathom Pharmaceuticals, Inc. in every 13F filed by Decheng Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PHAT overviewAll 13F holders of PHATFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −694,254−100.0% | Sold out | Holders |
| Q4 2024 | 694,254 | $5.64M | 1.2% | −555,746−44.5% | Reduced | Holders |
| Q3 2024 | 1,250,000 | $22.6M | 5.4% | +400,000+47.1% | Added | Holders |
| Q2 2024 | 850,000 | $8.76M | 2.7% | 00.0% | Unchanged | Holders |
| Q1 2024 | 850,000 | $9.03M | 1.2% | 00.0% | Unchanged | Holders |
| Q4 2023 | 850,000 | $7.76M | 2.2% | – | No prior filing | Holders |